Oral antiviral drug Paxlovid™ (nirmatrelvir/ritonavir) may be offered to high-risk adults with mild-to-moderate COVID-19 who do not require hospital care.
For detailed information on providing Paxlovid™ please visit BCPhA’s Paxlovid™ Resources for Pharmacists page.